These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22506770)

  • 21. Identification of sibling species of the bryozoan Bugula neritina that produce different anticancer bryostatins and harbor distinct strains of the bacterial symbiont "Candidatus Endobugula sertula".
    Davidson SK; Haygood MG
    Biol Bull; 1999 Jun; 196(3):273-80. PubMed ID: 10390826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells.
    May WS; Sharkis SJ; Esa AH; Gebbia V; Kraft AS; Pettit GR; Sensenbrenner LL
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8483-7. PubMed ID: 3317410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of a des-B-ring bryostatin analogue leads to an unexpected ring expansion of the bryolactone core.
    Kraft MB; Poudel YB; Kedei N; Lewin NE; Peach ML; Blumberg PM; Keck GE
    J Am Chem Soc; 2014 Sep; 136(38):13202-8. PubMed ID: 25207434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bryostatin-1: pharmacology and therapeutic potential as a CNS drug.
    Sun MK; Alkon DL
    CNS Drug Rev; 2006; 12(1):1-8. PubMed ID: 16834754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unlocking the Drug Potential of the Bryostatin Family: Recent Advances in Product Synthesis and Biomedical Applications.
    Wu R; Chen H; Chang N; Xu Y; Jiao J; Zhang H
    Chemistry; 2020 Jan; 26(6):1166-1195. PubMed ID: 31479550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
    Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM
    Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural insights into the interactions of phorbol ester and bryostatin complexed with protein kinase C: a comparative molecular dynamics simulation study.
    Thangsunan P; Tateing S; Hannongbua S; Suree N
    J Biomol Struct Dyn; 2016 Jul; 34(7):1561-75. PubMed ID: 26292580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogs in LNCaP and U937 cancer cell lines provides insight into their differential mechanism of action.
    Kedei N; Telek A; Michalowski AM; Kraft MB; Li W; Poudel YB; Rudra A; Petersen ME; Keck GE; Blumberg PM
    Biochem Pharmacol; 2013 Feb; 85(3):313-24. PubMed ID: 23146662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substitution on the A-ring confers to bryopyran analogues the unique biological activity characteristic of bryostatins and distinct from that of the phorbol esters.
    Keck GE; Poudel YB; Welch DS; Kraft MB; Truong AP; Stephens JC; Kedei N; Lewin NE; Blumberg PM
    Org Lett; 2009 Feb; 11(3):593-6. PubMed ID: 19113896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study of bryostatin 1 in patients with relapsed multiple myeloma.
    Varterasian ML; Pemberton PA; Hulburd K; Rodriguez DH; Murgo A; Al-Katib AM
    Invest New Drugs; 2001; 19(3):245-7. PubMed ID: 11561682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for the biosynthesis of bryostatins by the bacterial symbiont "Candidatus Endobugula sertula" of the bryozoan Bugula neritina.
    Davidson SK; Allen SW; Lim GE; Anderson CM; Haygood MG
    Appl Environ Microbiol; 2001 Oct; 67(10):4531-7. PubMed ID: 11571152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells.
    Dale IL; Bradshaw TD; Gescher A; Pettit GR
    Cancer Res; 1989 Jun; 49(12):3242-5. PubMed ID: 2720677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein kinase C activator bryostatin-1 modulates proteasome function.
    Khan TK; Nelson TJ
    J Cell Biochem; 2018 Aug; 119(8):6894-6904. PubMed ID: 29693282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of [3H]bryostatin 4 to protein kinase C.
    Lewin NE; Dell'Aquila ML; Pettit GR; Blumberg PM; Warren BS
    Biochem Pharmacol; 1992 May; 43(9):2007-14. PubMed ID: 1596288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity.
    Wender PA; Baryza JL; Brenner SE; DeChristopher BA; Loy BA; Schrier AJ; Verma VA
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6721-6. PubMed ID: 21415363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of [26-3H]bryostatin 1 and analogs to calcium-dependent and calcium-independent protein kinase C isozymes.
    Kazanietz MG; Lewin NE; Gao F; Pettit GR; Blumberg PM
    Mol Pharmacol; 1994 Aug; 46(2):374-9. PubMed ID: 8078499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The novel cytotoxic sponge metabolite peloruside A, structurally similar to bryostatin-1, has unique bioactivity independent of protein kinase C.
    Hood KA; Bäckström BT; West LM; Northcote PT; Berridge MV; Miller JH
    Anticancer Drug Des; 2001; 16(2-3):155-66. PubMed ID: 11962513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simple analogue of tumor-promoting aplysiatoxin is an antineoplastic agent rather than a tumor promoter: development of a synthetically accessible protein kinase C activator with bryostatin-like activity.
    Nakagawa Y; Yanagita RC; Hamada N; Murakami A; Takahashi H; Saito N; Nagai H; Irie K
    J Am Chem Soc; 2009 Jun; 131(22):7573-9. PubMed ID: 19449873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective binding of bryostatin analogues to the cysteine rich domains of protein kinase C isozymes.
    Wender PA; Lippa B; Park CM; Irie K; Nakahara A; Ohigashi H
    Bioorg Med Chem Lett; 1999 Jun; 9(12):1687-90. PubMed ID: 10397502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Designed PKC-targeting bryostatin analogs modulate innate immunity and neuroinflammation.
    Abramson E; Hardman C; Shimizu AJ; Hwang S; Hester LD; Snyder SH; Wender PA; Kim PM; Kornberg MD
    Cell Chem Biol; 2021 Apr; 28(4):537-545.e4. PubMed ID: 33472023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.